We show that the sCD163/sTWEAK ratio is significantly increased in patients with scleroderma compared with healthy subjects, and that a high sCD163/sTWEAK ratio is associated with greater skin involvement but lower risk of DU in SSc. The gene discussed is CD163; the disease is systemic sclerosis.